SG11201608710TA - Anti-enterovirus 71 thiadiazolidine derivative - Google Patents

Anti-enterovirus 71 thiadiazolidine derivative

Info

Publication number
SG11201608710TA
SG11201608710TA SG11201608710TA SG11201608710TA SG11201608710TA SG 11201608710T A SG11201608710T A SG 11201608710TA SG 11201608710T A SG11201608710T A SG 11201608710TA SG 11201608710T A SG11201608710T A SG 11201608710TA SG 11201608710T A SG11201608710T A SG 11201608710TA
Authority
SG
Singapore
Prior art keywords
enterovirus
thiadiazolidine
derivative
thiadiazolidine derivative
Prior art date
Application number
SG11201608710TA
Inventor
Peng Li
Haiying He
Ning Li
Jian Li
Shuhui Chen
Bailing Yang
Wang Shen
Wei Xiao
Original Assignee
Jiangsu Kanion Parmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CN201410543064.6A external-priority patent/CN105085512A/en
Application filed by Jiangsu Kanion Parmaceutical Co Ltd filed Critical Jiangsu Kanion Parmaceutical Co Ltd
Priority claimed from PCT/CN2015/077043 external-priority patent/WO2015165340A1/en
Publication of SG11201608710TA publication Critical patent/SG11201608710TA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/101,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433Thidiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
SG11201608710TA 2014-04-28 2015-04-21 Anti-enterovirus 71 thiadiazolidine derivative SG11201608710TA (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CN201410176161 2014-04-28
CN201410543064.6A CN105085512A (en) 2014-04-28 2014-10-14 Enteric virus 71 (EV71)-resistant thiadiazolidine derivatives
CN201510182757 2015-04-16
PCT/CN2015/077043 WO2015165340A1 (en) 2014-04-28 2015-04-21 Anti-enterovirus 71 thiadiazolidine derivative

Publications (1)

Publication Number Publication Date
SG11201608710TA true SG11201608710TA (en) 2016-11-29

Family

ID=56755307

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201608710TA SG11201608710TA (en) 2014-04-28 2015-04-21 Anti-enterovirus 71 thiadiazolidine derivative

Country Status (10)

Country Link
US (1) US9988361B2 (en)
EP (1) EP3138840B1 (en)
JP (1) JP6389531B2 (en)
KR (2) KR20160147010A (en)
CN (1) CN106661009B (en)
DK (1) DK3138840T3 (en)
ES (1) ES2841418T3 (en)
MY (1) MY176508A (en)
SG (1) SG11201608710TA (en)
TW (1) TWI658037B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2835061T3 (en) * 2015-10-26 2021-06-21 Jiangsu Kanion Pharmaceutical Co Ltd Salt form and crystalline form of 1,2,5-thiadiazolidine 1,1-dioxide, method of preparation thereof and intermediates
CN113940918B (en) 2020-07-17 2023-06-02 江苏康缘药业股份有限公司 Pharmaceutical composition and preparation method thereof
CN114539020B (en) * 2022-01-17 2023-12-08 南京迈诺威医药科技有限公司 Preparation method of 1, 5-dibromo-3, 3-difluoropentane

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9104136D0 (en) * 1991-02-27 1991-04-17 Merck Sharp & Dohme Therapeutic agents
DE4107857A1 (en) * 1991-03-12 1992-09-17 Thomae Gmbh Dr K CYCLIC UREA DERIVATIVES, MEDICAMENTS CONTAINING SUCH COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF
US5852192A (en) * 1992-03-11 1998-12-22 Dr. Karl Thomae Gmbh Cyclic urea derivatives, pharmaceutical compositions containing these compounds and processes for preparing them
SK94393A3 (en) * 1992-09-11 1994-08-10 Thomae Gmbh Dr K Cyclic derivatives of urea, process for their production and their pharmaceutical agents with the content of those
GB9715816D0 (en) * 1997-07-25 1997-10-01 Black James Foundation Histamine H receptor ligands
US7019026B1 (en) * 1999-09-10 2006-03-28 Novo Nordisk A/S Modulators of Protein Tyrosine Phosphatases (PTPases)
FR2803298A1 (en) * 1999-12-30 2001-07-06 Adir NOVEL LINEAR OR CYCLIC UREAS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US7129359B2 (en) * 2002-07-09 2006-10-31 National Health Research Institutes Imidazolidinone compounds
US6706739B2 (en) * 2001-08-21 2004-03-16 National Health Research Institute Imidazolidinone compounds
AU2003256755A1 (en) * 2002-07-24 2004-02-09 Ptc Therapeutics, Inc. Ureido substituted benzoic acid compounds, their use for nonsense suppression and the treatment of diseases caused by such mutations
US7259174B2 (en) * 2004-05-25 2007-08-21 National Health Research Institutes Imidazolidinone compounds
JP2008506702A (en) * 2004-07-14 2008-03-06 ピーティーシー セラピューティクス,インコーポレーテッド Method for treating hepatitis C
EP1948629A1 (en) * 2005-10-31 2008-07-30 Janssen Pharmaceutica N.V. Substituted piperazines and piperidines as modulators of the neuropeptide y2 receptor
KR20080076916A (en) * 2005-11-01 2008-08-20 트랜스테크 파르마, 인크. Pharmaceutical use of substituted amides
CA2660201C (en) * 2006-08-15 2016-05-03 Novartis Ag Organic compounds
CA2729663A1 (en) * 2008-07-02 2010-01-07 Avexa Limited Compounds having antiviral properties
WO2010029048A1 (en) * 2008-09-09 2010-03-18 Sekmed Srl 1, 2, 5-thiadiazole derivatives useful as immune potentiators
CN102344416B (en) * 2010-08-02 2015-09-16 中国人民解放军军事医学科学院毒物药物研究所 Pyridazine derivatives and the purposes as Antipicornaviral infection medicine thereof
CN102485717B (en) * 2010-12-06 2015-12-02 中国人民解放军军事医学科学院毒物药物研究所 Thiazole sulfonamide derivatives and the purposes as Antipicornaviral infection medicine thereof
KR101332805B1 (en) * 2011-03-31 2013-11-27 한국화학연구원 Derivatives Having Adamantyl Group and Pharmaceutical Acceptable Salts Thereof
GB201402169D0 (en) * 2014-02-07 2014-03-26 Isis Innovation Viral inhibitors

Also Published As

Publication number Publication date
MY176508A (en) 2020-08-12
EP3138840B1 (en) 2020-09-23
DK3138840T3 (en) 2020-12-21
EP3138840A4 (en) 2017-12-20
ES2841418T3 (en) 2021-07-08
TW201620885A (en) 2016-06-16
JP6389531B2 (en) 2018-09-12
EP3138840A1 (en) 2017-03-08
KR20180069103A (en) 2018-06-22
JP2017513914A (en) 2017-06-01
TWI658037B (en) 2019-05-01
US20170066732A1 (en) 2017-03-09
US9988361B2 (en) 2018-06-05
CN106661009B (en) 2019-11-26
KR101957178B1 (en) 2019-03-12
CN106661009A (en) 2017-05-10
KR20160147010A (en) 2016-12-21

Similar Documents

Publication Publication Date Title
GB201413037D0 (en) Beyond 10
ZA201704602B (en) Dihydroindolizinone derivative
GB201418612D0 (en) Umajin 1
IL248772A0 (en) Cyclohexyl-pyridine derivative
SG11201608710TA (en) Anti-enterovirus 71 thiadiazolidine derivative
GB201418846D0 (en) MicroSub 1
GB201416254D0 (en) LiftEye 2014
GB201414175D0 (en) Pris-map 1
GB201418606D0 (en) Lifteye october 2014
GB201413386D0 (en) Taggstar 2
GB201413310D0 (en) Taggstar 2
GB201413313D0 (en) Kapiche 1
GB201412713D0 (en) Soundwall 2
GB201408307D0 (en) Pakaging 22
GB201408330D0 (en) Pckaging 32
GB201406497D0 (en) Skytag 2
GB201401037D0 (en) 54545
GB201408333D0 (en) Concept 15
GB201408337D0 (en) Concept 23
GB201408336D0 (en) Concept 22
GB201408335D0 (en) Concept 21
GB201408334D0 (en) Concept 16
GB201408341D0 (en) Concept 31
GB201408310D0 (en) Concept 11
GB201408344D0 (en) Concept 44